Scientists have discovered a unique group of cells that can undergo programmed cell death, survive it, and then help repair damaged tissues. These cells, called DARE cells, were identified by researchers at the Weizmann Institute of Science in a study published in Nature Communications. The findings suggest that DARE cells may be key to tissue regeneration, but they could also play a role in cancer recurrence after treatment. Tissues like skin and the epithelial layers that cover internal organs have a remarkable ability to repair themselves after injury. This process, known as compensatory proliferation, was first observed in the 1970s when fly larvae exposed to high radiation were able to regenerate fully functional wings. Since then, similar regenerative responses have been seen in many species, including humans. The study highlights a surprising role for caspases, enzymes typically linked to cell death, in helping certain cells survive the process. These surviving cells can then help rebuild damaged tissue and may become more resistant to future injuries. However, this same survival mechanism could be exploited by cancer cells, potentially leading to more aggressive and treatment-resistant tumors. Dr. Tslil Braun and her team at the Weizmann Institute studied this process by exposing fruit fly larvae to ionizing radiation and using advanced genetic tools to track tissue regeneration. They discovered a population of cells that activated an initiator caspase but survived the radiation. These cells, named DARE cells, not only survived but also multiplied, repaired the damaged tissue, and replenished nearly half of it within 48 hours. In contrast, a second group of death-resistant cells, called NARE cells, did not activate the initiator caspase. DARE cells were crucial for regeneration, as removing them eliminated the regenerative response. They were activated by signals from neighboring cells undergoing death. The study found that DARE cells could survive radiation levels that would cause nearby cells to die through apoptosis. While the death process started normally in DARE cells, it stalled before the executioner caspases could complete the destruction. A protein known as a molecular motor was found to anchor the initiator caspase to the cell membrane, preventing it from triggering the executioner caspases. Disabling this motor protein impaired tissue regeneration, hinting at a possible link to cancer growth. Descendants of DARE cells were also found to be seven times more resistant to cell death than the original cells, which may explain why some tumors become more resistant after radiation therapy. The researchers also uncovered a feedback loop between DARE and NARE cells that helps maintain balance in tissue repair. DARE cells promote the growth of nearby NARE cells by releasing growth signals, while NARE cells release signals that limit DARE cell growth, preventing overgrowth. Although the experiments were conducted in fruit flies, further research is needed to understand how these mechanisms work in humans. The findings could lead to new strategies for improving tissue repair and preventing cancer recurrence.